Delivery Order SPE2DB22D1202-SPE2DB24FVJD2
Award Date
7/29/24
Potential Completion Date
7/30/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,084.02, is for the delivery of Naftifine HCL 1% Cream 90GM, a pharmaceutical product. The contract has a ceiling value of $2,084.02 and an ultimate completion date of February 26, 2025. It is a firm fixed-price contract type. The contract is not designated as a set-aside....
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,036.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide NAFTIFINE HCL 1% CREAM 60GM. The contract has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor and has an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is a Delivery Order valued at $1,385.12 for the supply of 4565752999 - Naftifine HCL 2% Cream 45GM. The contract was awarded by the Defense Logistics Agency (DLA) and does not have a set-aside designation. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other agencies, valued at up to $999,999,999 and $750,000 respectively,...
This is a firm fixed price delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $2,834.52 order is for the delivery of NAFTIFINE HCL 1% CREAM 60GM, a pharmaceutical product, with a completion date of January 18, 2024. Amerisourcebergen Drug Corp has a history of providing pharmaceuticals, medical supplies, and related distribution...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NAFTIFINE HCL 1% CREAM 60GM, with a ceiling value of $1,166.53 and a period of performance through November 18, 2024. The contract was awarded on November 15, 2024 and is a Firm Fixed Price Delivery Order. This award is not designated with a set-aside. AmerisourceBergen holds a...
The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $5,778.20 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565745808 - Naftifine HCL 1% Cream 60GM. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which allows the agency to efficiently procure a comprehensive range of medical commodities,...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order (DO) valued at $4,737.94 for the supply of NAFTIFINE HCL 1% CREAM 60GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2023. The contract type is Firm Fixed Price, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, with ID SPE2DB20D1047|SPE2DB25FF43E, was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,390.33, is for the delivery of NAFTIFINE HCL 2% CREAM 45GM, a pharmaceutical product. The contract is a delivery order with a firm fixed price, and the ultimate completion date is February 18, 2025. This award is not designated as a set-aside contract....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order valued at $1,873.54 for the supply of 4556611118 - Naftifine HCL 1% Cream 60GM. The contract has an ultimate completion date of March 21, 2022 and was awarded on March 18, 2022 under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a for-profit organization and subsidiary of Amerisourcebergen Corporation. The $24,326.12 firm fixed price delivery order is for the supply of NAFTIFINE HCL 2% GEL 45GM, a pharmaceutical product. The award has an ultimate completion date of April 1, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31,...